Skip to content
Home
About
Team
Our Board
Management Team
Clinical Ambassadors
Corporate Governance
Our Name & Brandmark
Care Delivery
Pax Centre
Emerald Clinics
Maritime Health Clinic
Drug and Therapy Development
Psychedelic-Assisted Therapy
Ultra-Pure CBD Medicines
MDMA-inspired Medicines
Research & Data Programs
Investor Hub
Shareholder Communications
News
General News
Blogs
Publications
Investor Updates
In the Media
Contact
Menu
Home
About
Team
Our Board
Management Team
Clinical Ambassadors
Corporate Governance
Our Name & Brandmark
Care Delivery
Pax Centre
Emerald Clinics
Maritime Health Clinic
Drug and Therapy Development
Psychedelic-Assisted Therapy
Ultra-Pure CBD Medicines
MDMA-inspired Medicines
Research & Data Programs
Investor Hub
Shareholder Communications
News
General News
Blogs
Publications
Investor Updates
In the Media
Contact
Publications
May 10, 2023
Study finds Medicinal Cannabis May Have Impact on Quality of Life
November 21, 2022
Emyria RWE Registry analysis demonstrates safety & efficacy of oral medicinal cannabis
March 24, 2022
Publication: Zelira/Emyria Observational Study Whitepaper
January 24, 2022
Publication: Real-World Evidence in Medicinal Cannabis Research
December 18, 2021
Publication: Pharmacokinetics, Safety, & Tolerability of a Medicinal Cannabis Formulation in Patients with Chronic Non-cancer Pain
September 9, 2020
Publication: Cannabis – are there any benefits?
March 14, 2020
Publication: Use of cannabinoid-based medicine among older residential care recipients diagnosed with dementia
Search
Search
Search
Blogs
General News
In the Media
Information
Investor Updates
Publications
Uncategorised